玻璃体腔内注射Avastin治疗糖尿病视网膜病变研究进展
摘要
糖尿病视网膜病变（diabetic retinopathy，DR）是糖尿病的严重并发症之一，是各国主要致盲性眼病。玻璃体腔注射血管内皮生长因子（VEGF）单克隆抗体bevacizumab（商品名Avastin）是治疗DR的一种安全、有效、经济方法，但有关其长期疗效及重复注射的安全性尚存在争议。
出处
《中国实用眼科杂志》
CSCD
北大核心
2013年第11期1391-1393,共3页
Chinese Journal of Practical Ophthalmology
参考文献20
-
1Arevalo JF,Sanchez JG,Lasave AF,et al. Intravitreal Bevacizum- ab (Avastin (R)) for Diabetic Retinopathy at 2g-months: The 2008 Juan Verdaguer-Planas Lecture [J]. Curr Diabetes Rev, 2010,6(5) :313-322.
-
2Davidovic SP, Nikolic SV, Curic NJ, et al. Changes of serum VEGF concentration after intravitreal injection of Avastin in treatment of diabetic retinopathy [ J 1. Eur J Ophthalmol, 2012: 22 ( 5 ) : 792-798.
-
3Hattori T,Shimada H,Nakasbizuka H,et al. Dose of intravitreal bevacizumab(Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy [Jl. Retina, 2010, 30 (5) : 761-764.
-
4Avery RL, Pearlman J, Pieramici D J, et al. Intravitreal bevaci- zumab(Avastin)in the treatment of proliferative diabetic retinop- athy [ J ] Ophthalmology, 2006,113 (10) : 1695 e 1-15.
-
5Minnella AM,Savastano CM,Ziccardi L,et al. Intravitreal bevaci- zumab (Avastin) in proliferative diabetic retinopathy [J]. Aeta Ophthalmol, 2008,86( 6 ) : 683-687.
-
6Arevalo JF, Wu L, Sanchez JG, et al. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months fol- low-up[J]. Eye(Lond) ,2009,23( 1 ) : 117-123.
-
7Thew M. Rapid resolution of severe retinal neovascularisation in proliferative diabetic retinopathy following adjunctive intravit- real bevacizumab (Avastin) [J]. Clin Exp Optom, 2009, 92 (1) : 34-37.
-
8Mason JO, Yunker J J, Vail R, et al. Intravitreal bevacizumab (Avastin)prevention of panretinal photocoagulation-indueed com- plications in patients with severe proliferative diabetic retinopa- thy[J]. Retina,2008,28(9) : 1319-1324.
-
9Spaide RF, Fisher YL. Intravitreal bevaeizumab(Avastin) treat- ment of proliferative diabetic retinopathy complicated by vitre-ous hemorrhage[J]. Retina,2006,26(3):275-278.
-
10Mason JO,Nixon PA,White MF. Intravitreal injection of bevaci- zumab(Avastin)as adjunctive treatment of proliferative diabetic retinopathy[J]. Am J Ophthalmol,2006,142(4):685-688.
-
1谢柏如,汪瑞娟,顾宝文,周玺,向旭明.复方血栓通胶囊联合治疗糖尿病性视网膜病变的疗效观察[J].中国实用医药,2011,6(23):141-142. 被引量：8
-
2熊道元,黄一丹,林婉意.玻璃体腔注射Avastin治疗糖尿病性黄斑水肿的护理[J].现代医院,2010,10(11):89-90. 被引量：2
-
3萨如拉,佟艳秋,赵玉环.玻璃体腔内注射Avastin治疗糖尿病视网膜病变的临床研究[J].国际眼科杂志,2011,11(1):94-96. 被引量：2
-
4李艳.抗癌药Avastin有损心脏[J].中国保健营养,2005(1):78-78.
-
5Avastin关键词：静脉血栓[J].中国处方药,2008(11):20-20.
-
6陈长华.眼部B超在Avastin治疗糖尿病视网膜病变随访研究中的作用[J].中国医药指南,2011,9(4):66-68. 被引量：3
-
7新一代抗癌药贝伐单抗致静脉血栓栓塞风险增加[J].世界临床药物,2008,29(12):764-764.
-
8佟莉杨,李甦雁.玻璃体腔注射贝伐单抗治疗增生性糖尿病视网膜病变[J].国际眼科纵览,2014,0(6):400-402. 被引量：2
-
9赵全良,张春香,萨如拉.血管内皮生长因子抑制剂球内注射治疗糖尿病性黄斑水肿[J].国际眼科杂志,2011,11(12):2164-2166.
-
10周云燕,张仁俊.Avastin联合曲安奈德玻璃体腔注射治疗糖尿病视网膜病变伴黄斑水肿[J].国际眼科杂志,2010,10(3):475-476. 被引量：9
